STOCK TITAN

Lilly to participate in Bernstein's 2nd Annual Healthcare Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Eli Lilly (NYSE:LLY) announced its participation in Bernstein's 2nd Annual Healthcare Forum on September 25, 2025. The company's CFO, Lucas Montarce, will participate in a fireside chat at 8:00 AM ET.

Investors can access a live audio webcast through Lilly's investor website, with a replay available for approximately 90 days following the event.

Eli Lilly (NYSE:LLY) ha confermato la sua partecipazione al 2° Bernstein Annual Healthcare Forum il 25 settembre 2025. Il CFO dell'azienda, Lucas Montarce, prenderà parte a un fireside chat alle 8:00 AM ET.

Gli investitori potranno seguire la diretta audio tramite il sito per gli investitori di Lilly; la registrazione sarà disponibile in replay per circa 90 giorni dopo l'evento.

Eli Lilly (NYSE:LLY) anunció su participación en el 2.º Bernstein Annual Healthcare Forum el 25 de septiembre de 2025. El director financiero de la compañía, Lucas Montarce, participará en un fireside chat a las 8:00 AM ET.

Los inversores podrán acceder a la retransmisión de audio en vivo a través del sitio web de inversores de Lilly; la grabación quedará disponible en replay durante aproximadamente 90 días tras el evento.

Eli Lilly (NYSE:LLY)는 2025년 9월 25일에 열리는 Bernstein 제2회 연례 Healthcare Forum에 참여한다고 발표했습니다. 회사의 CFO인 Lucas Montarce는 동부시간(ET) 오전 8시에 대담(fireside chat)에 참여할 예정입니다.

투자자들은 Lilly 투자자 웹사이트를 통해 오디오 생중계를 들을 수 있으며, 행사가 끝난 후 약 90일 동안 다시보기(replay)가 제공됩니다.

Eli Lilly (NYSE:LLY) a annoncé sa participation au 2e Bernstein Annual Healthcare Forum le 25 septembre 2025. Le directeur financier, Lucas Montarce, prendra part à un fireside chat à 8h00 (ET).

Les investisseurs peuvent accéder au webcast audio en direct via le site investisseurs de Lilly ; un replay sera disponible pendant environ 90 jours après l'événement.

Eli Lilly (NYSE:LLY) gab bekannt, dass das Unternehmen am 2. Bernstein Annual Healthcare Forum am 25. September 2025 teilnimmt. Der CFO, Lucas Montarce, wird um 8:00 Uhr ET an einem Fireside-Chat teilnehmen.

Investoren können den Audio-Livestream über Lilys Investorenseite abrufen; eine Wiederholung (Replay) steht etwa 90 Tage nach der Veranstaltung zur Verfügung.

Positive
  • None.
Negative
  • None.

INDIANAPOLIS, Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025. Lucas Montarce, executive vice president and chief financial officer, will take part in a fireside chat at 8 a.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY

Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Refer to:   

Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media)


Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors)

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-bernsteins-2nd-annual-healthcare-forum-302553180.html

SOURCE Eli Lilly and Company

FAQ

When is Eli Lilly (LLY) presenting at Bernstein's Healthcare Forum 2025?

Eli Lilly will present at 8:00 AM Eastern Time on September 25, 2025.

Who will represent Eli Lilly (LLY) at the Bernstein Healthcare Forum?

Lucas Montarce, Eli Lilly's executive vice president and chief financial officer, will represent the company in a fireside chat.

How can investors access Eli Lilly's (LLY) Bernstein Healthcare Forum presentation?

Investors can access the live audio webcast through Lilly's investor website at investor.lilly.com, with a replay available for approximately 90 days.

What type of presentation will Eli Lilly (LLY) give at the Bernstein Healthcare Forum?

Eli Lilly's CFO will participate in a fireside chat format presentation.
Lilly Eli & Co

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

662.16B
944.35M
0.16%
83.87%
0.8%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS